Inhibit This: SGLT2 and PCSK9 Inhibitors in PAD
Presenter
Marc P. Bonaca, MD, MPH, University of Colorado School of Medicine, Aurora, CO
Marc P. Bonaca, MD, MPH, University of Colorado School of Medicine, Aurora, CO
Learning Objectives:
- Describe new medications for reducing cardiovascular risk.
- Describe pathways of action.
- Describe data supporting their use.
Keywords: Peripheral Artery Disease (PAD) and Pharmacotherapy